Manulife (Manufacturers Life Insurance)
MAZE

Manulife (Manufacturers Life Insurance)’s Maze Therapeutics MAZE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$435K Buy
14,570
+7,673
+111% +$339K ﹤0.01% 2218
2025
Q4 		$286K Buy
+6,897
New +$237K ﹤0.01% 2378

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Manulife (Manufacturers Life Insurance)'s MAZE Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Maze Therapeutics (MAZE) stake by 111% in Q1 2026, buying an estimated $339K and bringing the position to 14,570 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

Manulife (Manufacturers Life Insurance) first reported a position in MAZE in Q4 2025 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold MAZE as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 14,570 shares of Maze Therapeutics worth $435K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 7,673 Maze Therapeutics shares in Q1 2026, an estimated $339K.
  • Maze Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2218 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Maze Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 165 funds tracked by Wall St. Rank held Maze Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.